Sex-based differences in safety and efficacy of catheter ablation for atrial fibrillation.
arrhythmias
atrial fibrillation
catheter ablation
cryoballoon ablation
radiofrequency ablation
sex differences
Journal
Journal of cardiovascular electrophysiology
ISSN: 1540-8167
Titre abrégé: J Cardiovasc Electrophysiol
Pays: United States
ID NLM: 9010756
Informations de publication
Date de publication:
08 2023
08 2023
Historique:
revised:
28
05
2023
received:
11
04
2023
accepted:
09
06
2023
medline:
10
8
2023
pubmed:
27
6
2023
entrez:
27
6
2023
Statut:
ppublish
Résumé
Studies have identified significant sex-based differences and disparities in the clinical presentation and treatment of atrial fibrillation (AF). Studies have shown women are less likely to be referred for catheter ablation, are older at the time of ablation, and are more likely to have recurrence after ablation. However, in most studies investigating AF ablation outcomes, the female cohorts were relatively small. The impact of sex on the outcome and safety of ablation procedures is still unclear. To investigate sex-based differences in outcomes and complications after AF catheter ablation, with a significant female cohort METHOD: In this retrospective study, patients undergoing AF ablation from January 1, 2014, to March 31, 2021, were included. We investigated clinical characteristics, duration and progression of AF, number of EP appointments from diagnosis to ablation, procedural data, and procedure complications. Total of 1346 patients underwent first catheter ablation for AF during this period, including 896 (66.5%) male and 450 (33.4%) female patients. Female patients were older at the time of ablation (66.2 vs. 62.4 years; p < .001). Women had higher CHA Female patients were older and had higher CHA
Sections du résumé
BACKGROUND
Studies have identified significant sex-based differences and disparities in the clinical presentation and treatment of atrial fibrillation (AF). Studies have shown women are less likely to be referred for catheter ablation, are older at the time of ablation, and are more likely to have recurrence after ablation. However, in most studies investigating AF ablation outcomes, the female cohorts were relatively small. The impact of sex on the outcome and safety of ablation procedures is still unclear.
OBJECTIVE
To investigate sex-based differences in outcomes and complications after AF catheter ablation, with a significant female cohort METHOD: In this retrospective study, patients undergoing AF ablation from January 1, 2014, to March 31, 2021, were included. We investigated clinical characteristics, duration and progression of AF, number of EP appointments from diagnosis to ablation, procedural data, and procedure complications.
RESULTS
Total of 1346 patients underwent first catheter ablation for AF during this period, including 896 (66.5%) male and 450 (33.4%) female patients. Female patients were older at the time of ablation (66.2 vs. 62.4 years; p < .001). Women had higher CHA
CONCLUSION
Female patients were older and had higher CHA
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1640-1647Informations de copyright
© 2023 Wiley Periodicals LLC.
Références
Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation. Circulation. 2014;129(8):837-847. doi:10.1161/circulationaha.113.005119
Poli D, Antonucci E. Epidemiology, diagnosis, and management of atrial fibrillation in women. Int J Women's Health. 2015;7:605. doi:10.2147/ijwh.s45925
Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics-2022 update: a report from the American Heart Association. Circulation. 2022;145(8):e153-639. doi:10.1161/cir.0000000000001052
Dagres N, Nieuwlaat R, Vardas PE, et al. Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe. JACC. 2007;49(5):572-577. doi:10.1016/j.jacc.2006.10.047
Volgman AS, Benjamin EJ, Curtis AB, et al. Women and atrial fibrillation. J Cardiovasc Electrophysiol. 2020;32(10):2793-2807. doi:10.1111/jce.14838
Friberg J, Scharling H, Gadsbøll N, Truelsen T, Jensen GB. Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (the Copenhagen City Heart Study). Am J Cardiol. 2004;94(7):889-894. doi:10.1016/j.amjcard.2004.06.023
Olesen JB, Lip GYH, Hansen ML, et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ. 2011;342(1):d124. doi:10.1136/bmj.d124
Fang MC, Singer DE, Chang Y, et al. Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation. Circulation. 2005;112(12):1687-1691. doi:10.1161/circulationaha.105.553438
Westerman S, Wenger N. Gender differences in atrial fibrillation: a review of epidemiology, management, and outcomes. Curr Cardiol Rev. 2019;15(2):136-144. doi:10.2174/1573403x15666181205110624
Piccini JP, Simon DN, Steinberg BA, et al. Differences in clinical and functional outcomes of atrial fibrillation in women and men. JAMA Cardiol. 2016;1(3):282. doi:10.1001/jamacardio.2016.0529
Rienstra M, Van Veldhuisen DJ, Hagens VE, et al. Gender-related differences in rhythm control treatment in persistent atrial fibrillation. JACC. 2005;46(7):1298-1306. doi:10.1016/j.jacc.2005.05.078
Forleo GB, Tondo C, De Luca L, et al. Gender-related differences in catheter ablation of atrial fibrillation. EP Europace. 2007;9(8):613-620. doi:10.1093/europace/eum144
Avgil Tsadok M, Gagnon J, Joza J, et al. Temporal trends and sex differences in pulmonary vein isolation for patients with atrial fibrillation. Heart Rhythm. 2015;12(9):1979-1986. doi:10.1016/j.hrthm.2015.06.029
Takigawa M, Kuwahara T, Takahashi A, et al. Differences in catheter ablation of paroxysmal atrial fibrillation between males and females. Int J Cardiol. 2013;168(3):1984-1991. doi:10.1016/j.ijcard.2012.12.101
Kaiser DW, Fan J, Schmitt S, et al. Gender differences in clinical outcomes after catheter ablation of atrial fibrillation. JACC Clin Electrophysiol. 2016;2(6):703-710. doi:10.1016/j.jacep.2016.04.014
Santangeli P, Di Biase L, Pelargonio G, Natale A. Outcome of invasive electrophysiological procedures and gender: are males and females the same? J Cardiovasc Electrophysiol. 2010;22(5):605-612. doi:10.1111/j.1540-8167.2010.01920.x
Schnabel RB, Pecen L, Ojeda FM, et al. Gender differences in clinical presentation and 1-year outcomes in atrial fibrillation. Heart. 2017;103(13):1024-1030. doi:10.1136/heartjnl-2016-310406
Weerasooriya R, Khairy P, Litalien J, et al. Catheter ablation for atrial fibrillation. JACC. 2011;57(2):160-166. doi:10.1016/j.jacc.2010.05.061
Marrouche NF, Wilber D, Hindricks G, et al. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. JAMA. 2014;311(5):498-506. doi:10.1001/jama.2014.3
Chelu MG, King JB, Kholmovski EG, et al. Atrial fibrosis by late gadolinium enhancement magnetic resonance imaging and catheter ablation of atrial fibrillation: 5-year follow-up data. J Am Heart Assoc. 2018;7(23):e006313. doi:10.1161/JAHA.117.006313
Kirchhof P, Camm AJ, Goette A, et al. Early rhythm-control therapy in patients with atrial fibrillation. N Engl J Med. 2020;383(14):1305-1316. doi:10.1056/NEJMoa2019422
Packer DL, Kowal RC, Wheelan KR, et al. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation. JACC. 2013;61(16):1713-1723. doi:10.1016/j.jacc.2012.11.064
Zhao Y, Krupadev V, Dagher L, et al. Pharmacological rhythm versus rate control in patients with atrial fibrillation and heart failure: the CASTLE-AF trial. J Interv Card Electrophysiol. 2021;61(3):609-615. doi:10.1007/s10840-020-00856-1
Cheng X, Hu Q, Gao L, Liu J, Qin S, Zhang D. Sex-related differences in catheter ablation of atrial fibrillation: a systematic review and meta-analysis. EP Europace. 2019;21(10):1509-1518. doi:10.1093/europace/euz179
Park YJ, Park J-W, Yu HT, et al. Sex difference in atrial fibrillation recurrence after catheter ablation and antiarrhythmic drugs. Heart. 2023;109(7):519-526. doi:10.1136/heartjnl-2021-320601
Mohanty S, Trivedi C, Gianni C, Natale A. Gender specific considerations in atrial fibrillation treatment: a review. Expert Opin Pharmacother. 2018;19:365-374.